ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years
Mengmeng Du
Matched on ORCID iD 0000-0001-6156-1491; OpenAlex author ID A5071998663. Sources: OpenAlex.
Their work
- Papers
- 15 (first author 2, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 30
2020: 5 papers · 2021: 3 papers · 2022: 2 papers · 2023: 2 papers · 2024: none · 2025: none · 2026: 3 papers
Papers 15
- Polygenic scores for risk of pancreatic ductal adenocarcinoma: evaluation of novel and published models. Co-author DOI 10.1038/s41698-026-01479-x↗
- Different diabetes types and pancreatic ductal adenocarcinoma: a Mendelian randomization and pathway/gene-set analysis. Co-author DOI 10.1093/jnci/djaf308↗
- Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals Co-author DOI 10.64898/2026.04.21.26351329↗
- Association of Polycystic Ovary Syndrome With Pancreatic Cancer-Reply. First author DOI 10.1001/jamaoncol.2023.0178↗
- Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. Co-author DOI 10.1158/1055-9965.epi-23-0453↗
- Incidence of Pancreatic Cancer by Age and Sex in the US From 2000 to 2018. First author DOI 10.1001/jama.2022.2309↗
- Association Between Polycystic Ovary Syndrome and Risk of Pancreatic Cancer. Last author DOI 10.1001/jamaoncol.2022.4540↗
- A 584 bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancer. Co-author DOI 10.1016/j.ajhg.2021.09.002↗
- Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Co-author DOI 10.1093/ajcn/nqab217↗
- Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3. Co-author DOI 10.1158/0008-5472.can-20-3267↗
- A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djz246↗
- Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk. Co-author DOI 10.1158/0008-5472.can-20-0447↗
- Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-20-0091↗
- Genome-Wide Gene-Diabetes and Gene-Obesity Interaction Scan in 8,255 Cases and 11,900 Controls from PanScan and PanC4 Consortia. Co-author DOI 10.1158/1055-9965.epi-20-0275↗
- Mendelian Randomization Analysis of n-6 Polyunsaturated Fatty Acid Levels and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-20-0651↗
Closest collaborators
The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Noah Charles Peeri · 2 shared papers, 2022–2023 · strength 0.57
- Fergus Keane · 1 shared paper, 2022 · strength 0.26
- Eileen Mary O'Reilly · 1 shared paper, 2022 · strength 0.26
- Robert C. Kurtz · 1 shared paper, 2022 · strength 0.19
- Jirong Long · 1 shared paper, 2020 · strength 0.07
- Eric J. Duell · 1 shared paper, 2020 · strength 0.07
- Roger Laughlin Milne · 1 shared paper, 2020 · strength 0.07
- Rachel Ε. Neale · 1 shared paper, 2020 · strength 0.07
- Lang Wu · 1 shared paper, 2020 · strength 0.07
- Xiang Shu · 1 shared paper, 2020 · strength 0.07
- Federico Canzian · 1 shared paper, 2020 · strength 0.07
- Stephen K. Van Den Eeden · 1 shared paper, 2020 · strength 0.07
- Verena Andrea Katzke · 1 shared paper, 2020 · strength 0.07
- Jingjing Zhu · 1 shared paper, 2020 · strength 0.07
- Emily White · 1 shared paper, 2020 · strength 0.07
- Duo Liu · 1 shared paper, 2020 · strength 0.07
- Wei Zheng · 1 shared paper, 2020 · strength 0.07
- Herbert Yu · 1 shared paper, 2020 · strength 0.07
- Núria Malats Riera · 1 shared paper, 2020 · strength 0.07
- Rachael Z. Stolzenberg‐Solomon · 1 shared paper, 2020 · strength 0.07
- Alison P. Klein · 1 shared paper, 2020 · strength 0.07
- Harvey A. Risch Risch · 1 shared paper, 2020 · strength 0.07
- Ghislaine Scélo · 1 shared paper, 2020 · strength 0.07
- Xiao‐Ou Shu · 1 shared paper, 2020 · strength 0.07
- Steve Gallinger · 1 shared paper, 2020 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.